iPSC-Derived Biological Pacemaker—From Bench to Bedside
Author Information
Author(s): Vo Quan Duy, Nakamura Kazufumi, Saito Yukihiro, Iida Toshihiro, Yoshida Masashi, Amioka Naofumi, Akagi Satoshi, Miyoshi Toru, Yuasa Shinsuke
Primary Institution: Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Hypothesis
Induced pluripotent stem cell (iPSC)-derived biological pacemakers can serve as an alternative to traditional electronic pacemakers for managing cardiac arrhythmias.
Conclusion
iPSC-derived biological pacemakers show promise as a more natural and effective solution for cardiac rhythm management, but significant challenges remain for clinical application.
Supporting Evidence
- iPSC-derived pacemakers mimic the natural function of the sinoatrial node.
- Preclinical studies show successful integration of iPSC-derived cardiomyocytes into host cardiac tissue.
- Challenges in achieving long-term functionality and managing immune responses remain significant.
Takeaway
Scientists are trying to use special cells called iPSCs to create new types of heart pacemakers that work better and are safer than the old electronic ones.
Methodology
This review discusses advancements in differentiation protocols and preclinical studies of iPSC-derived biological pacemakers.
Limitations
Challenges include achieving cellular maturity, long-term functionality, and managing immune responses.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website